Metabolic rate and longevity: capacity, stress and the cost of illness

The number does not explain its cause

A higher resting metabolic rate is not automatically evidence of better health. Equally, a lower value is not automatically evidence of successful energy conservation. Before interpreting either, we need to ask what the body is spending energy on, how much functioning tissue it has, and whether it is maintaining or losing that tissue.

This is an important distinction for EPK—energy per kilogram—and its emphasis on fuelling function. A measure of energy expenditure describes a cost. It does not, by itself, measure capacity, comfort, recovery or healthspan.

A mouse study challenges a simple rate-of-living rule

Speakman and colleagues reported that mice in the highest quarter of metabolic intensity had 17% higher resting oxygen consumption and lived 36% longer than those in the lowest quarter. Greater mitochondrial proton conductance accompanied the comparison. These were associations within an outbred mouse cohort, not a randomised treatment that raised metabolism to extend life. [1]

The paper challenges a universal claim that faster metabolism necessarily shortens life. It does not establish that deliberately increasing human expenditure—or inducing mitochondrial uncoupling—improves longevity. Detailed methods and statistical appraisal remain limited here because the full text was unavailable; the reported comparison comes from the primary abstract.

Human findings point in more than one direction

In the Baltimore Longitudinal Study of Aging, a study of 1,227 participants linked higher basal metabolic rate with higher mortality after adjustment for several risk factors. The authors interpreted an unusually limited age-related decline as potentially reflecting poor health. An observational association does not show that lowering expenditure would prevent deaths. [2]

Another Baltimore analysis, involving 619 participants, associated higher RMR with greater skeletal-muscle oxidative capacity after adjustment for body composition and other factors. Oxidative capacity was assessed through post-exercise phosphocreatine recovery, not inferred from calories alone. This cross-sectional result cannot establish a lifespan effect. [3]

These are not interchangeable outcomes. The practical lesson is to retain the clinical and functional context, rather than choosing whichever association supports a preferred direction for metabolism.

Fever: an increased cost during illness

A study of sedated, critically ill patients with fever found that external cooling lowered temperature from about 39.1°C to 37.1°C alongside a reduction in measured expenditure from 2,034 to 1,791 kcal/day. That is a concrete example of a higher metabolic cost accompanying illness, rather than evidence of superior fitness. [4]

It should not become a universal calories-per-degree rule. Sedation, the illness and temperature-management conditions matter. Nor does this experiment establish that suppressing every fever improves outcomes. Its relevance here is measurement: an elevated expenditure reading needs an explanation.

Catecholamines can raise resting expenditure

Ratheiser and colleagues infused epinephrine—adrenaline—into thirteen healthy men and measured expenditure with indirect calorimetry. Resting expenditure increased by about 12% during the prolonged infusion. The increase persisted after the initial heart-rate response had subsided. [5]

This demonstrates a mechanism by which adrenergic stimulation can raise expenditure. It is not a measurement of the calorie cost of an ordinary stressful meeting, and it cannot supply a general “stress multiplier” for an app. It also cautions against assuming that pulse alone reliably tells us how much energy a person is using.

Catabolism: losing tissue while expenditure is high

Catabolism refers to breaking down molecules and tissues; it is not a synonym for high resting metabolism. The two can occur together. In a randomised trial of twenty-five children with severe burns, propranolol reduced resting expenditure and improved net muscle-protein balance compared with untreated controls. [6]

That trial supplies direct evidence for the distinction between burning more energy and preserving the body. It concerns specialist care after major burns, not a reason to use beta blockers for routine fatigue, dieting or longevity.

The relationship can also change over time. A longitudinal Baltimore analysis associated several chronic diseases with higher initial resting expenditure and a steeper subsequent decline. An early energetic burden and later loss of metabolically active tissue may therefore appear in the same clinical trajectory. [7]

What an EPK study should measure

The implication is not to disregard metabolism. It is to measure enough to interpret it. An EPK study should record illness, temperature, relevant medication, body composition and recent weight change alongside expenditure. Repeated measures should use comparable conditions, and acute illness should be considered separately from stable health.

Functional outcomes should carry their own weight: maintaining strength, recovering from activity and sustaining daily life are not interchangeable with achieving a high calorie-burn figure. An increase in expenditure with preserved tissue and better function has a different meaning from an increase accompanied by fever, distress and wasting.

The metabolism theme in Consistent Eating provides the broad question—what work does the body need fuel to perform? These studies sharpen it. A useful research framework must distinguish the energy cost of maintaining health from the extra cost imposed by illness, without assuming that either a high or low resting value supplies the answer on its own.

Related EPK articles

• Healthspan needs outcomes beyond metabolic rate
• Does calorie restriction always worsen wellbeing? The CALERIE counterpoint
• The energy cost of stress: appetite, food quality and the demands of coping

Related working papers

Read the relevant PDFs: EPK–001 to 007 are the revised version 1.2 papers; EPK–008 to 010 are version 1.0 supplements. Earlier PDFs and DOI records remain on the paper archive.